XCELLA BIOSCIENCES INC has a total of 25 patent applications. It decreased the IP activity by 61.0%. Its first patent ever was published in 2016. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and EPO (European Patent Office). Its main competitors in its focus markets biotechnology, chemical engineering and measurement are MYCARTIS NV, MCDEVITT JOHN T and AMERSHAM BIOSCIENCES SV CORP.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 8 | |
#2 | United States | 6 | |
#3 | EPO (European Patent Office) | 4 | |
#4 | Australia | 3 | |
#5 | Canada | 2 | |
#6 | China | 2 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Chemical engineering | |
#3 | Measurement | |
#4 | Organic fine chemistry | |
#5 | Pharmaceuticals |
# | Name | Total Patents |
---|---|---|
#1 | Chen Bob | 20 |
#2 | Cochran Jennifer R | 8 |
#3 | Alford Spencer Caleb | 6 |
#4 | Cochran Jennifer | 3 |
#5 | Hsieh Vivian | 2 |
#6 | Wittrup Karl Dane | 2 |
#7 | Alford Spencer | 2 |
#8 | Kelly Ryan | 2 |
#9 | Kelly Ryan Lewis | 2 |
#10 | Tan Ming | 1 |
Publication | Filing date | Title |
---|---|---|
WO2020210151A1 | Methods and systems for screening using microcapillary arrays | |
WO2020186098A1 | Vista-binding antibodies and uses thereof | |
WO2020186111A2 | Vista-binding antibodies and uses thereof | |
WO2020185952A1 | Cd27-binding antibodies and uses thereof | |
US2020316593A1 | Lateral loading of microcapillary arrays | |
WO2018191180A1 | High-throughput absorbance measurements of samples in microcapillary arrays | |
AU2018207303A1 | Combination tumor treatment with an integrin-binding-Fc fusion protein and immune modulator | |
WO2018125832A1 | Multi-stage sample recovery system | |
CN110268108A | Method and system for using Microcapillary array to be screened | |
US2018163198A1 | Methods and systems for screening using microcapillary arrays |